Survival and lung transplant outcomes for individuals with advanced cystic fibrosis lung disease in the United States and Canada: an analysis of national registries.

[1]  S. Stanojevic,et al.  Bridging the survival gap in cystic fibrosis: An investigation of lung transplant outcomes in Canada and the United States. , 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  M. Skeans,et al.  Impact of Socioeconomic Position on Access to the US Lung Transplant Waiting List in a Matched Cystic Fibrosis Cohort. , 2020, Annals of the American Thoracic Society.

[3]  C. Benden,et al.  Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease. , 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[4]  C. Goss,et al.  UNDERWEIGHT PATIENTS WITH CYSTIC FIBROSIS HAVE ACCEPTABLE SURVIVAL AFTER LUNG TRANSPLANTATION: A UNOS REGISTRY STUDY. , 2020, Chest.

[5]  C. Teneback,et al.  Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial , 2019, The Lancet.

[6]  L. Lands,et al.  Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele. , 2019, The New England journal of medicine.

[7]  N. Daniels,et al.  Should Lack of Social Support Prevent Access to Organ Transplantation? , 2019, The American journal of bioethics : AJOB.

[8]  B. Meiser,et al.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  J. Pilewski,et al.  Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[10]  J. Crapo,et al.  Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals , 2019, Annals of the American Thoracic Society.

[11]  Amélie Quesnel-Vallée,et al.  Canada's universal health-care system: achieving its potential , 2018, The Lancet.

[12]  Erika D. Lease,et al.  Heterogeneity in Survival in Adult Patients With Cystic Fibrosis With FEV1 < 30% of Predicted in the United States , 2017, Chest.

[13]  J. Golden,et al.  Effect of Lung Transplantation on Health‐Related Quality of Life in the Era of the Lung Allocation Score: A U.S. Prospective Cohort Study , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  S. Stanojevic,et al.  Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States , 2017, Annals of Internal Medicine..

[15]  Aliza K Fink,et al.  The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry. , 2016, Annals of the American Thoracic Society.

[16]  C. Goss,et al.  Predictors of non-referral of patients with cystic fibrosis for lung transplant evaluation in the United States. , 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[17]  G. Tomlinson,et al.  Effects of Recipient Age and Diagnosis on Health-related Quality-of-Life Benefit of Lung Transplantation. , 2015, American journal of respiratory and critical care medicine.

[18]  G. A. Whitmore,et al.  Clinical and demographic factors associated with post-lung transplantation survival in individuals with cystic fibrosis. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  C. Merlo,et al.  National Healthcare Delivery Systems Influence Lung Transplant Outcomes for Cystic Fibrosis , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  S. Stanojevic,et al.  Global Lung Function Initiative equations improve interpretation of FEV1 decline among patients with cystic fibrosis , 2015, European Respiratory Journal.

[21]  C. Goss,et al.  Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic status. , 2012, American journal of respiratory and critical care medicine.

[22]  S. Stanojevic,et al.  Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.

[23]  M. Corey,et al.  Socioeconomic status and risk of hospitalization among individuals with cystic fibrosis in Ontario, Canada , 2011, Pediatric pulmonology.

[24]  P. Cullinan,et al.  Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007 , 2011, BMJ : British Medical Journal.

[25]  K. Bramstedt,et al.  Too Poor for Transplant: Finance and Insurance Issues in Transplant Ethics , 2010, Progress in transplantation.

[26]  K. Gorey.  Breast cancer survival in Canada and the USA: meta-analytic evidence of a Canadian advantage in low-income areas. , 2009, International journal of epidemiology.

[27]  M. Simmerling.  Beyond scarcity: poverty as a contraindication for organ transplantation. , 2007, The virtual mentor : VM.

[28]  Hhs Centers for Medicare Medicare Services.  Medicare program; hospital conditions of participation: requirements for approval and re-approval of transplant centers to perform organ transplants. Final rule. , 2007, Federal register.

[29]  F L Grover,et al.  Development of the New Lung Allocation System in the United States , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[30]  D. Schaubel,et al.  Mortality After Kidney Transplantation: A Comparison Between the United States and Canada , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[31]  Gopal K. Singh,et al.  Area deprivation and widening inequalities in US mortality, 1969-1998. , 2003, American journal of public health.

[32]  Cathy J Bradley,et al.  Race, socioeconomic status, and breast cancer treatment and survival. , 2002, Journal of the National Cancer Institute.

[33]  P. Margolis,et al.  The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. , 2001, American journal of respiratory and critical care medicine.

[34]  P D Cleary,et al.  Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. , 2001, Journal of clinical epidemiology.

[35]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[36]  K. Gorey,et al.  An international comparison of cancer survival: Toronto, Ontario, and Detroit, Michigan, metropolitan areas. , 1997, American journal of public health.

[37]  M. Corey,et al.  Determinants of mortality from cystic fibrosis in Canada, 1970-1989. , 1996, American journal of epidemiology.

[38]  Raymond J. Carroll,et al.  Estimation and comparison of changes in the presence of informative right censoring by modeling the censoring process , 1988 .

[39]  C. Goss,et al.  The future of cystic fibrosis care: a global perspective. , 2020, The Lancet. Respiratory medicine.

[40]  Shaf Keshavjee,et al.  A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[41]  C. Merlo,et al.  Insurance status is an independent predictor of long-term survival after lung transplantation in the United States. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[42]  R. Pampalon,et al.  A deprivation index for health planning in Canada. , 2009, Chronic diseases in Canada.

[43]  E. Kliewer,et al.  An international comparison of breast cancer survival: Winnipeg, Manitoba and Des Moines, Iowa, metropolitan areas. , 2003, Annals of epidemiology.